CATHETER REMOVAL side effect
What is CATHETER REMOVAL ?CATHETER REMOVAL : Imatinib Side Effects Report #5389846-3
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on July 10, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Imatinib Side Effects Report #5397366-5
IMATINIB MESYLATE problem was reported by a Physician from UNITED KINGDOM on July 18, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Imatinib Side Effects Report #5389846-3
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on July 10, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Imatinib Side Effects Report #5397366-5
IMATINIB MESYLATE problem was reported by a Physician from UNITED KINGDOM on July 18, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Imatinib Side Effects Report #5430440-3
Physician from UNITED KINGDOM reported IMATINIB MESYLATE problem on Aug 24, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia, . IMATINIB MESYLATE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Cetuximab Side Effects Report #5392012-9
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Female patient, weighting 142.2 lb, was diagnosed with laryngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter removal, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 IV QW. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Cetuximab Side Effects Report #5392012-9
Health Professional from UNITED STATES reported CETUXIMAB problem on July 17, 2007. Female patient, weighting 142.2 lb, was diagnosed with laryngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter removal, staphylococcal infection, . CETUXIMAB dosage: 250MG/M2 IV QW. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Myfortic Side Effects Report #5654677-3
MYFORTIC problem was reported by a Physician from GERMANY on Feb 27, 2008. Male patient, 53 years of age, was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood creatinine increased, catheter removal, epididymal infection, femoral nerve palsy, hydronephrosis, nephrostomy, post procedural infection, transplant rejection, . MYFORTIC dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.
CATHETER REMOVAL : Myfortic Side Effects Report #5575376-2
Physician from GERMANY reported MYFORTIC problem on Dec 20, 2007. Male patient, 53 years of age, was diagnosed with renal transplant and was treated with MYFORTIC. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood creatinine increased, catheter removal, epididymal infection, femoral nerve palsy, hydronephrosis, nephrostomy, post procedural infection, transplant rejection, . MYFORTIC dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.